INTRODUCTION
Vulvar cancer is the fourth most common gynecological cancer and comprises 5% of all malignancies of the female genital tract [1] . Two distinct types of vulvar intraepithelial neoplasia (VIN) with different pathogenesis, molecular events, morphological features and risk of progression to squamous carcinoma are determined [2] . A more common 'usual type of VIN' (also referred to as classic, undifferentiated, basaloid, warty, bowenoid type) is related to infection with Human Papillomavirus (HPV) which has a low risk of progression to invasive carcinoma. However, the chances of finding invasive cancer within the lesion of a usual type VIN cannot be excluded. A rarer, 'differentiated' (simplex) non-HPV-related VIN type is sometimes associated with lichen sclerosus, and it has a high risk of progression to invasive lesions. Incidence of the usual type VIN and HPVrelated invasive vulvar cancer has been increasing, especially in younger women [3, [4] [5] [6] .
Genital infection with HPV is usually transient since the immune system is able to eliminate the virus. However, VIN may develop during persistent viral infection in the case of immune system failure. The natural history of VIN development and progression/regression is not fully elucidated, especially in pregnancy [7] . Pregnancy may contribute to spontaneous regression of VIN3, but the recurrence of VIN 3 twelve weeks after resection of vulvar cancer during pregnancy has been described [8] .
Some data suggest that inflammatory activation in the dermis is reflected by the influx of NK cells and T cells as a response on viral HPV infection in VIN patients [9] . Studies describing the distribution of immunocompetent cells on VIN lesions are very limited [9] . The observed increase of NK cells in the dermis of the usual-type VIN lesions is in accordance with activation of the innate immune response. CD4+CD25+ T regs cells play an important role in the mechanism of escape from immune surveillance in the process of tumour progression, and T regs suppress the tumour specific immune response [10] . The expression of factor forkhead boxP3 (FOXP3), a marker of T regs, was detected within vulvar cancer cell nests and in the tumor stroma. Recently, T regs were detected as a significantly higher population in the tumor compared with normal tissues [11] .
Elevated numbers of peripheral blood NK cells and increased infiltration of endometrial NK cells have been reported as complications related to pregnancy, such as miscarriage [12, 13] . Although immunophenotypes of the majority of peripheral blood NK cells are different from endometrial NK cells, the peripheral blood NK cells seem to be keenly related to decidual NK cells and may reflect the decidual NK cell functional status [12] [13] [14] . It is now also accepted that uterine NK cells are at least partially derived from blood [14] . Additionally, some data suggest that women with RM have altered peripheral blood NK parameters, and NK cells as a percentage of lymphocytes best discriminate RM and control women [15] [16] [17] .
OBJECTIVE
The aim of the study was to determine peripheral blood NK cell and T reg activity after partial vulvectomy in pregnant women with VIN 3. According to current knowledge, there exist only very limited data regarding immune aspects during pregnancy complicated by VIN.
MATERIALS AND METHODS
A 36-year-old pregnant woman, 16 weeks into her second pregnancy, second delivery, was studied. Gestational age was assigned on the last menstrual period and ultrasound examination. Consent for the study was obtained from the Bioethics Committee of the Military Institute of Medicine and from the patient. The patient was HPV-DNA (6, 11, 16, 18 , 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) negative (cervical smear). Colposkopy was satisfactory with no abnormalities observed. According to vulvar biopsy performed with vulvoscopy at 16 weeks of gestation and histologic diagnosis: dysplasia maioris gradus et partim carcinomatosa intraepidermale (in situ) epithelii superficialis vulvae (VIN 3; CIS) the patient underwent partial vulvectomy-surgical excision at 22 weeks of gestation because of increased spread of vulvar changes. Final histologic results were as follow: carcinoma intraepidermale Bowenoidale (in situ) with free surgical margins 1-2 mm. Subsequentl pregnancy outcome was uncomplicated. However, routine high-risk obstetrics care, including periodic uterine ultrasonography and foetal heart monitoring, was provided. A normal, healthy boy of 2,720 g was delivered by caesarean section at 37 weeks of gestation. Two weeks after delivery, simple hemivulvectomy was performed because of clinically suspected changes of the vulvae and narrow free surgical margins after the previous operation, according to patient request. However, histologic examination of the removed vulvar tissue revealed no abnormalities.
Flow Cytometry analysis of NK cells. Natural killer cell activity was measured using flow cytometry. The NK cells' methodology has been described previously [17] . The peripheral blood NK cells' surface antigens CD16, CD56 were also studied using flow cytometry (Simultest CD3/ CD16+CD56, FACSCalibur, Cell Quest software, BectonDickinson).
NK assay -Separations of effector cells. Peripheral blood mononuclear cells (PBMC) were isolated from heparinized blood of the patient by Ficoll gradient centrifugation. The mononuclear cells are adjusted to 1×10 7 cells/2.6ml in culture medium (RPMI 1640, 10% FBS). Target cells were human erythroleukemia K562 (ATTC, UK). The K562 human erythroleukemia cell line is used as a standard target for human NK assays. K562 cells were washed in PBS 120g and labeled with 1.2ml DIO (3,3-dioctadecyloxacarbocyxacarbocyanine perchlorate, (Sigma)/1ml PBS and incubated for 20min in 37 °C CO 2 . After two washes in PBS, cell concentration was adjusted to 1×10 6 cells/ml in medium (RPMI 1640, 10% FBS) and used for cytotoxity assay.
Cytotoxity assay. Groups of eight replicate wells were incubated for 4h in 37 0 C 5%CO 2 : PBMC in medium, K562 in medium, mixed PBMC with target cells in ratios: 50:1 and 12:1. 25 ml propidium iodide solution (0.1mg/ml in water, Sigma) was added to each sample to stain dead cells (total volume in each sample 0.2 ml). Live target cells (T) were identified by strong green fluorescence, whereas dead target cells (Td) showed strong green and red fluorescence. The percentage of dead target cells (%Td) was calculated as follows: %Td=(Td / T)×100%. Specific lysis was calculated as %Td (cultured with effector cells -%Td (cultured without effector cells). 
RESULTS
Flow cytometry analysis revealed a decrease in the number of NK cells and their activity after the operation on the study woman (Tab. 1; Fig. 1 ). In addition, the T reg population was decreased; however, their activity increased after the operation (Figs. 2, 7) .
DISCUSSION
Regression of VIN can occur in young women before their thirties, especially during pregnancy. However, the chances of finding invasive cancer within the lesions of the usual type VIN range between 15 -22% [18] [19] [20] . Therefore, the decision to perform vulvectomy because of the progression of the lesion was made very rapidly.
Some data suggest that expression of CD4+CD25+ T reg correlates with persistence of HPV type 16. T regs may inhibit the HPV clearance by immune cells, such as NK cells [21] . Recent data of Kojima et al. demonstrate that CD4+CD25+ Foxp3+ T regs infiltration into cervical intraepithelial neoplasia (CIN) lesions, a lesion similar to VIN, significantly correlates with regression of CIN, regardless of the HPV subtype. Conversely, a high prevalence of lesional cervical Tregs may be a biomarker for HPV infection persistence and CIN progression [22] . Similar mechanism may also be involved in VIN progression. 
CONCLUSIONS
In the study case, vulvectomy changed the immune parameters. It cannot be excluded the that operation was necessary for a successful pregnancy outcome, because increased NK cell parameters are associated with adverse pregnancy outcomes, including miscarriage. However, this issue merits further study which, however, is very difficult to perform since pregnant patients with VIN are rather rare in the clinical setting, and no generally accepted standards and recommendation of managements exist. 
